-transparent.png){kind=logo}
An improved ADCC assay for the detection of cancer-associated serum blocking factors is described. Inhibition of ADCC by sera was performed without preincubation and washing of effector cells. Effects of individual susceptibility of normal effector cells to serum inhibitors and of the background inhibition by normal sera were also avoided. Based on their inhibitory effect on ADCC, normal and tumour sera from lung cancer patients could be distinguished with 81.4 to 100% accuracy, according to effector cell donors and to concentrations of the sera tested.
Related Publications
B Fekete, and
L Sachno, and
K Tamássy, and
A Pál, and
I Angyal, and
I Forrai
June 1979,
Immunology,
B Fekete, and
L Sachno, and
K Tamássy, and
A Pál, and
I Angyal, and
I Forrai
May 1980,
International journal of cancer,
B Fekete, and
L Sachno, and
K Tamássy, and
A Pál, and
I Angyal, and
I Forrai
May 1977,
Journal of the National Cancer Institute,
B Fekete, and
L Sachno, and
K Tamássy, and
A Pál, and
I Angyal, and
I Forrai
January 1999,
Methods in molecular medicine,
B Fekete, and
L Sachno, and
K Tamássy, and
A Pál, and
I Angyal, and
I Forrai
October 1974,
Journal of immunology (Baltimore, Md. : 1950),
B Fekete, and
L Sachno, and
K Tamássy, and
A Pál, and
I Angyal, and
I Forrai
July 1976,
Clinical and experimental immunology,
B Fekete, and
L Sachno, and
K Tamássy, and
A Pál, and
I Angyal, and
I Forrai
February 1999,
Breast cancer research and treatment,
B Fekete, and
L Sachno, and
K Tamássy, and
A Pál, and
I Angyal, and
I Forrai
July 1977,
Orvosi hetilap,
B Fekete, and
L Sachno, and
K Tamássy, and
A Pál, and
I Angyal, and
I Forrai
February 1999,
Hybridoma,
B Fekete, and
L Sachno, and
K Tamássy, and
A Pál, and
I Angyal, and
I Forrai
January 1977,
Scandinavian journal of immunology,
